Search results
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 6 days agoThe Pfizer and GSK shots are available to people age 60 and older. Women can also get the Pfizer...
A Message from Mr. COVID-19 – Again!
The Uniontown Herald Standard· 2 days agoOccasionally, I find myself engaging in nostalgia. In the past, I’ve written about the joys of penny candy; the pleasures of those Saturday afternoon-long kiddy shows down at the State Theatre ...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 6 days agoThe new omicron variant took only a few weeks to live up to dire predictions about how hugely...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 6 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 6 days agoOne reason for Moderna’s low sales is because Americans aren’t getting booster vaccines as...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 6 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Health Freedom Prevails Against the CDC and NIH
Mercola· 3 days agoIn the video above, Del Bigtree, founder of “The Highwire” and the Informed Consent Action Network (icandecide.org), shares some of the recent lawsuits ICAN has won against the National Institutes ...
